http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101201866-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-46 |
| filingDate | 2010-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101201866-B1 |
| titleOfInvention | Pharmaceutical composition for the prevention and treatment of cancer containing Komycin-A as an active ingredient |
| abstract | The present invention comprises a gomisin-A (gomisin-A) represented by the following formula (1), by containing the gomycin-A as an active ingredient to increase the activity of caspase-7 (caspase-7) to inhibit cancer cell growth It relates to a composition for anticancer drugs. [Formula 1] Gomisin-A according to the present invention can be usefully used as a prophylactic and therapeutic agent for inhibiting cancer cell growth by inducing apoptosis of colorectal cancer cells through caspase-7 activity. have. In addition, Gomisin-A isolated from the herbal medicines are relatively addictive and side effects compared to drugs that are chemically synthesized and sold, can be added to various food compositions can be useful as an adjuvant for preventing and treating cancer diseases. |
| priorityDate | 2010-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 241.